Polyrizon Ltd. (NASDAQ:PLRZ) Sees Significant Increase in Short Interest

Polyrizon Ltd. (NASDAQ:PLRZ) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totaling 176,028 shares, a growth of 1,102.1% from the November 30th total of 14,643 shares. Currently, 16.9% of the shares of the stock are short sold. Based on an average trading volume of 16,817,222 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 16,817,222 shares, the short-interest ratio is presently 0.0 days. Currently, 16.9% of the shares of the stock are short sold.

Polyrizon Price Performance

Polyrizon stock traded up $0.38 during midday trading on Wednesday, hitting $7.61. 58,391 shares of the company’s stock were exchanged, compared to its average volume of 9,582,408. The stock has a 50-day moving average price of $6.92 and a two-hundred day moving average price of $6.41. Polyrizon has a 52-week low of $2.88 and a 52-week high of $4,200.00.

Analysts Set New Price Targets

Several brokerages recently commented on PLRZ. Wall Street Zen upgraded Polyrizon from a “strong sell” rating to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings restated a “sell (e+)” rating on shares of Polyrizon in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.